J. Timothy Greenamyre

Affiliations: 
University of Pittsburgh, Pittsburgh, PA, United States 
Area:
Parkinson's Disease, Huntington's Disease
Google:
"J. Timothy Greenamyre"
Mean distance: 15.16 (cluster 32)
 
SNBCP

Children

Sign in to add trainee
James G. Greene grad student 1992-1996 University of Rochester Medical Center
Deepa J. Talpade grad student 1996-1999 Emory University School of Medicine
David S. Wolf grad student 1997-2001 Emory University School of Medicine
David S. Wolf grad student 1997-2001 Emory University School of Medicine
Max P. Horowitz grad student 2007-2012 University of Pittsburgh
Roberto Di Maio post-doc 2008- University of Pittsburgh
Laurie H. Sanders post-doc 2008- University of Pittsburgh
Paul J. Barrett post-doc 2013- University of Pittsburgh
Amber Van Laar post-doc 2013- University of Pittsburgh
Briana R. DeMiranda post-doc 2014- University of Pittsburgh
Emily M. Rocha post-doc 2015- University of Pittsburgh
Richard  H. P. Porter post-doc 1992-1993 University of Rochester Medical Center
Donald S. Higgins post-doc 1992-1995 University of Pittsburgh
Blandini Fabio post-doc 1993-1995 University of Rochester Medical Center
Tsung-I Peng post-doc 1994-1998 University of Rochester Medical Center
Gillian MacKenzie post-doc 1996-1998 Emory University School of Medicine
Edward H. Pettus post-doc 1996-1999 Emory University School of Medicine
Stacy Stephans post-doc 1996-2000 Emory University School of Medicine
Todd B. Sherer post-doc 1999-2004 Emory University School of Medicine
Claudia M. Testa post-doc 2000-2004 Emory University School of Medicine
Robert Drolet post-doc 2007-2009 University of Pittsburgh
Federica Saporiti post-doc 2008-2009 University of Pittsburgh
Pier Giorgio Mastroberardino post-doc 2003-2010 University of Pittsburgh
Jason R. Cannon post-doc 2006-2011 University of Pittsburgh
Terina N. Martinez post-doc 2010-2013 University of Pittsburgh
Ranjita Betarbet research scientist 1996-2004 Emory University School of Medicine
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Keeney MT, Rocha EM, Hoffman EK, et al. (2024) LRRK2 regulates production of reactive oxygen species in cell and animal models of Parkinson's disease. Science Translational Medicine. 16: eadl3438
Pullara F, Forsmann MC, General IJ, et al. (2024) NADPH oxidase 2 activity disrupts Calmodulin/CaMKIIα complex via redox modifications of CaMKIIα-contained Cys30 and Cys289: Implications in Parkinson's disease. Redox Biology. 75: 103254
Keeney MT, Hoffman EK, Weir J, et al. (2024) 15-Lipoxygenase-Mediated Lipid Peroxidation Regulates LRRK2 Kinase Activity. Biorxiv : the Preprint Server For Biology
Ilieva NM, Hoffman EK, Ghalib MA, et al. (2024) LRRK2 kinase inhibition protects against Parkinson's disease-associated environmental toxicants. Neurobiology of Disease. 106522
Van Laar AD, Webb KR, Keeney MT, et al. (2023) Transient exposure to rotenone causes degeneration and progressive parkinsonian motor deficits, neuroinflammation, and synucleinopathy. Npj Parkinson's Disease. 9: 121
Di Maio R, Keeney MT, Cechova V, et al. (2023) Neuroprotective actions of a fatty acid nitroalkene in Parkinson's disease. Npj Parkinson's Disease. 9: 55
Hallacli E, Kayatekin C, Nazeen S, et al. (2022) The Parkinson's disease protein alpha-synuclein is a modulator of processing bodies and mRNA stability. Cell. 185: 2035-2056.e33
Keeney MT, Hoffman EK, Farmer K, et al. (2022) NADPH oxidase 2 activity in Parkinson's disease. Neurobiology of Disease. 105754
Rocha EM, Keeney MT, Di Maio R, et al. (2022) LRRK2 and idiopathic Parkinson's disease. Trends in Neurosciences
De Miranda BR, Goldman SM, Miller GW, et al. (2021) Preventing Parkinson's Disease: An Environmental Agenda. Journal of Parkinson's Disease
See more...